Randomized Controlled Trial of Adalimumab in Patients With Nonpsoriatic Peripheral Spondyloarthritis

OBJECTIVE: To evaluate the efficacy and safety of adalimumab in patients with active nonpsoriatic peripheral spondyloarthritis (SpA). METHODS: ABILITY-2 is an ongoing phase III, multicenter study of adalimumab treatment. Eligible patients age ≥18 years fulfilled the Assessment of SpondyloArthritis i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mease, Philip, Sieper, Joachim, Van den Bosch, Filip, Rahman, Proton, Karunaratne, P Mahinda, Pangan, Aileen L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409087/
https://www.ncbi.nlm.nih.gov/pubmed/25545240
http://dx.doi.org/10.1002/art.39008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409087/
https://www.ncbi.nlm.nih.gov/pubmed/25545240
http://dx.doi.org/10.1002/art.39008

Ejemplares similares